Tests Start on U.S.-Backed Drug for Stress Disorder | Employee …

November 3, 2008, Basel, Switzerland - Clinical trials have begun on a commencing U.S-backed drug to treat the debilitating feeling of heightened vigilance practised by veterans by post-traumatic stress, Swiss-based pharmaceutical company Synosia said Monday.

The study is funded with $1.4 million from the U.S. Defense Department and will converging-point on veterans of the wars in Iraq and Afghanistan, Synosia uttered.

The company before-mentioned it hopes the physic, called nepicastat, will help patients who have lost the ability to accurately assess danger, resulting in a firm sense of alertness.

The condition, known being of the class who hyperarousal, is one symptom of post-traumatic stress disorder. Others comprise sleeplessness, bad temper and exit from friends and family.

Post-traumatic significance disorder affects people from all walks of life, limit is specifically common in veterans. Some 40,000 U.S. troops have been diagnosed with the disorder because 2003.

The clinical testing will be conducted by researchers at veterans curative centers in Alabama, Texas and South Carolina, Synosia said.

Initial results about the effectiveness and tolerability of nepicastat are expected next take its source have its origin, said Synosia spokesman Jan Gregor. Synosia is conducting separate trials to example whether nepicastat is efficacious like a treatment for cocaine impose on.

This blog found on keywords:

• cheat drug testing dilute
• phentermine vs.cocaine
• fmla follow up drug testing
• 6633n sap 10-50 gc/ms, quest
• Analytical Toxicology Amoxicillin to Produce False-Positive Urine Screens for Cocaine
• austin teachers+drug test

Posted by admin November 2008

Post A Comment

Name (required)

Mail (will not be published) (required)

Website